These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8899116)

  • 21. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells.
    Bissonnette EY; Befus AD
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):825-31. PubMed ID: 9438493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects.
    Dente FL; Bancalari L; Bacci E; Bartoli ML; Carnevali S; Cianchetti S; Di Franco A; Giannini D; Vagaggini B; Testi R; Paggiaro PL
    Thorax; 1999 Jul; 54(7):622-4. PubMed ID: 10377209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways.
    Bolton PB; Lefevre P; McDonald DM
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1428-35. PubMed ID: 9105089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo pharmacologic modulation of basophil histamine release in asthmatic patients.
    Lebel B; Arnoux B; Chanez P; Bougeard YH; Daures JP; Bousquet J; Campbell AM
    Allergy; 1996 Jun; 51(6):394-400. PubMed ID: 8837662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
    Whelan CJ; Johnson M; Vardey CJ
    Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies.
    Martin RM; Shakir S
    Drug Saf; 2001; 24(6):475-81. PubMed ID: 11368253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against allergen-induced asthma by salmeterol.
    Twentyman OP; Finnerty JP; Harris A; Palmer J; Holgate ST
    Lancet; 1990 Dec; 336(8727):1338-42. PubMed ID: 1978163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
    Pedersen B; Dahl R; Larsen BB; Venge P
    Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
    Turner MO; Johnston PR; Pizzichini E; Pizzichini MM; Hussack PA; Hargreave FE
    Can Respir J; 1998; 5(4):261-8. PubMed ID: 9753527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury.
    McAuley DF; Frank JA; Fang X; Matthay MA
    Crit Care Med; 2004 Jul; 32(7):1470-6. PubMed ID: 15241090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma.
    Bacci E; Di Franco A; Bartoli ML; Carnevali S; Cianchetti S; Dente FL; Giannini D; Vagaggini B; Ruocco L; Paggiaro PL
    Eur Respir J; 2002 Jul; 20(1):66-72. PubMed ID: 12166584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study for characterization of IgE-mediated cutaneous immediate and late-phase reactions in non-allergic domestic cats.
    Seals SL; Kearney M; Del Piero F; Hammerberg B; Pucheu-Haston CM
    Vet Immunol Immunopathol; 2014 May; 159(1-2):41-9. PubMed ID: 24629765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
    Jeppsson AB; Nilsson E; Waldeck B
    Eur J Pharmacol; 1994 May; 257(1-2):137-43. PubMed ID: 8082695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics.
    Grutters JC; Brinkman L; Aslander MM; van den Bosch JM; Koenderman L; Lammers JW
    Eur Respir J; 1999 Oct; 14(4):915-22. PubMed ID: 10573242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo.
    Teixeira MM; Hellewell PG
    Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
    Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
    Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
    Brogden RN; Faulds D
    Drugs; 1991 Nov; 42(5):895-912. PubMed ID: 1723379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
    Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
    JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.